Evidence map›Paper›PMID 38125764›Full record

ArticleCancer innovation2023

Hepatoblastoma with neonatal necrotizing enterocolitis: Two case reports.

Sidou He, Xisi Wang, Chao Duan, Wen Zhao, Chiyi Jiang, Shihan Zhang, Binglin Jian, Wei Yang, Tong Yu, Libing Fu and 2 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cancer innovation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Sidou HeMedical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Xisi WangMedical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Chao DuanMedical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Wen ZhaoMedical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Chiyi JiangMedical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Shihan ZhangMedical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Binglin JianMedical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Wei YangSurgical Oncology Department, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Tong YuImaging Center Department, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Libing FuPathology Department, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Huanmin WangSurgical Oncology Department, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Xiaoli MaMedical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.ORCID https://orcid.org/0000-0001-7930-4944
Ministry of Education of the People's Republic of China · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report two children with hepatoblastoma (HB) with a history of neonatal necrotizing enterocolitis (NEC). Case 1 was diagnosed with HB at 5 months of age. Liver enlargement was found during the NEC operation at 3 months of age and then was clinically diagnosed by imaging. After six chemotherapy courses, a partial hepatectomy was performed. Three months after ceasing the chemotherapy, a chest computed tomography scan suggested that distant metastasis of the tumor should be considered, and the lesion was removed. However, 9 months after the operation, alpha-fetoprotein concentrations were increased, and abdominal imaging showed a recurrence of the tumor in situ, resulting in a hepatectomy. Case 2 was diagnosed with NEC shortly after birth and underwent an intestinal resection and anastomosis 1 month later. He was diagnosed with HB at 3 years of age. Hepatectomy was performed after five courses of chemotherapy. Chemotherapy was stopped after 10 courses, and alpha-fetoprotein concentrations were normal. At present, both children have survived and are in a healthy condition. Physicians should be aware of the possibility of HB and a history of NEC in children. Premature birth and low birth weight are common factors leading to the pathogenesis of HB and NEC. The association between these two diseases requires further study.

Indexed as

hepatoblastomaLGR5low birth weightneonatal necrotizing enterocolitispremature delivery

Identifiers

PMID38125764
PMCPMC10730001
OpenAlexW4385213213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.